Imported Goods Classified as "Yeast," Not "Medicament" - Appellant Directed to Predeposit

The Tribunal determined that the imported goods declared as "saccharomyces Boulardii" were correctly classified as "yeast" under Heading 2102, not as a "medicament" under Heading 3003. The appellant's claim lacked evidence that the goods were "put up as a medicament" at the time of importation, as required by Note 1 (f) to Chapter 21. The test report provided by the foreign manufacturer was deemed inconclusive. The Tribunal directed the appellant to make a predeposit of Rs.10,00,000 within a specified period under Section 129E of the Customs Act to potentially waive and stay the balance duty amount.

---

---

Issues:
Classification of imported goods under Customs Tariff Act, claim of classification as "medicament" under Heading 3003, applicability of Note 1 (f) to Chapter 21, relevance of test report from foreign manufacturer, requirement of predeposit under Section 129E of the Customs Act.

Classification of imported goods under Customs Tariff Act:
The appellant sought waiver and stay regarding Customs duty demanded for goods declared as "saccharomyces Boulardii" in the Bill of Entry under Heading 2918, while the authorities alleged the goods to be "yeast" under Heading 2102. The Tribunal found that the imported goods were indeed "yeast," classifiable under Heading 2102, as per the Central Excise Act precedent.

Claim of classification as "medicament" under Heading 3003:
The appellant claimed classification as "medicament" under Heading 3003, arguing the goods were meant for sale as a medicament. However, the Tribunal noted that the claim was not supported by evidence that the goods were "put up as a medicament" at the time of importation, as required by Note 1 (f) to Chapter 21.

Applicability of Note 1 (f) to Chapter 21:
The Tribunal highlighted that to exclude the product from Chapter 21, it must be demonstrated that the imported item was "put up as a medicament" at the time of importation. The appellant's claim failed to meet this criterion, leading to the rejection of their classification as a medicament under Heading 3003.

Relevance of test report from foreign manufacturer:
The appellant presented a test report from the foreign manufacturer to support their claim. However, the Tribunal deemed this report inconclusive and insufficient to substantiate the appellant's classification as a medicament under Heading 3003.

Requirement of predeposit under Section 129E of the Customs Act:
Since no prima facie case existed for the appellant, the Tribunal directed them to make a reasonable predeposit of Rs.10,00,000 within a specified period. Compliance with this directive would result in a waiver and stay in respect of the balance amount of duty, as per Section 129E of the Customs Act.

---